Year-Long trial tests if binge eating drug stays safe and effective
NCT ID NCT06878976
Summary
This study aims to see if the medication solriamfetol remains safe and effective for controlling binge eating disorder over a long period. It will follow 300 adults who have already completed a previous trial for about one year. The main goal is to monitor for any side effects while checking if the treatment continues to help reduce binge eating episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BINGE-EATING DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Encino, California, 91316, United States
-
Clinical Research Site
Long Beach, California, 90806, United States
-
Clinical Research Site
Santa Ana, California, 92705, United States
-
Clinical Research Site
Walnut Creek, California, 94596, United States
-
Clinical Research Site
West Covina, California, 91790, United States
-
Clinical Research Site
Cromwell, Connecticut, 06416, United States
-
Clinical Research Site
Fort Myers, Florida, 33912, United States
-
Clinical Research Site
Hialeah, Florida, 33012, United States
-
Clinical Research Site
Jacksonville, Florida, 32256, United States
-
Clinical Research Site
Lauderhill, Florida, 33319, United States
-
Clinical Research Site
Miami, Florida, 33145, United States
-
Clinical Research Site
Miami, Florida, 33176, United States
-
Clinical Research Site
Orlando, Florida, 32801, United States
-
Clinical Research Site
Marietta, Georgia, 30060, United States
-
Clinical Research Site
Overland Park, Kansas, 66210, United States
-
Clinical Research Site
Boston, Massachusetts, 02131, United States
-
Clinical Research Site
Saint Charles, Missouri, 63304, United States
-
Clinical Research Site
Cherry Hill, New Jersey, 08002, United States
-
Clinical Research Site
Mount Kisco, New York, 10549, United States
-
Clinical Research Site
New York, New York, 10128, United States
-
Clinical Research Site
Raleigh, North Carolina, 27607, United States
-
Clinical Research Site
Cincinnati, Ohio, 45215, United States
-
Clinical Research Site
Mason, Ohio, 45040, United States
-
Clinical Research Site
North Canton, Ohio, 44720, United States
-
Clinical Research Site
Portland, Oregon, 97210, United States
-
Clinical Research Site
North Charleston, South Carolina, 29405, United States
-
Clinical Research Site
Memphis, Tennessee, 38119, United States
-
Clinical Research Site
Austin, Texas, 78731, United States
-
Clinical Research Site
Austin, Texas, 78737, United States
-
Clinical Research Site
Dallas, Texas, 75251, United States
-
Clinical Research Site
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.